Major study launches to unravel mysteries of rare still disease in kids and adults
NCT ID NCT05927454
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 500 adults and children with Still disease, a rare inflammatory condition causing fever, joint pain, and rash. Researchers aim to compare how the disease affects different age groups, identify early markers, and improve care. No new treatments are being tested; instead, the goal is to gather information to guide future research and therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better understanding of Still disease, earlier diagnosis, and improved treatment strategies for both children and adults.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may take years to impact patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STILL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RaDiCo-AcoStill
RECRUITINGParis, Île-de-France Region, 75012, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- Pandemic stress hits hard for arthritis patients
- New drug combo aims to tame rare inflammatory disease
- 5,000 patients to help unlock secrets of inflammatory heart disease
- New study tracks ilaris use in rare inflammatory diseases across europe
- New drug aims to calm dangerous immune storms in Still's and lupus patients